Clinical trials in Beugen

Innovative research focusing on genotype-guided antithrombotic treatment for patients with peripheral arterial disease, aiming to reduce adverse clinical events related to arterial thrombosis.

• Arterial Thrombosis Prevention
• Cardiovascular Event Reduction
• Limb Preservation Strategies

Studies target improved outcomes in preventing major cardiovascular and limb events.

Groundbreaking research evaluating treatment strategies for multiple myeloma, comparing continuous therapy versus intermittent treatment approaches using novel drug combinations.

• Treatment-Free Intervals
• Disease Progression Monitoring
• Survival Outcomes Assessment

Focus on optimizing treatment duration and effectiveness for newly diagnosed patients.

Advanced studies investigating hormone receptor-positive breast cancer treatments, examining the optimal sequencing of endocrine therapy combined with CDK4/6 inhibition.

• Treatment Sequencing Strategies
• Progression-Free Survival
• Metastatic Disease Management

Evaluating first-line and second-line treatment combinations for improved patient outcomes.